 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 278 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Mori H. on PAPER: Tomiyama T. et al., 2010, The critique about Aβ oligomers in our paper is certainly an important issue since Aβ oligomers... 15 Apr 2010.
|
|
|
 |
|
|
Mori H. on PAPER: Grace EA. et al., 2003, This clearly demonstrates the involvement of amyloid in potent dystrophic neurite or curly fibre... 29 Jan 2003.
|
|
|
|
|
|
Mori H. on PAPER: Liu Y. et al., 2002, This provides a new insight in protein-degradation study as wellas Parkinson's Disease. It is... 14 Nov 2002.
|
|
|
|
|
|
Mori H. on PAPER: Kumar-Singh S. et al., 2002, More analyses on mutations near alpha-site are welcome because they should contribute to the... 14 Aug 2002.
|
|
|
|
|
|
Mori H. on PAPER: Nordberg A. et al., 2002, In spite of specificity of nicotine in light of AchR, this study may suggest a new clue in... 19 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Bancher C. et al., 1997, Tauopathy is an attractive study for the late AD pathogenesis and the effect of apoE e4 allele... 4 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Bancher C. et al., 1997, Tauopathy is an attractive study for the late AD pathogenesis and the effect of apoE e4 allele... 4 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Petit A. et al., 2001, It is an unexpected finding of the occurrence of an inhibitor to block APP-gamma secretase but... 4 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Li YM. et al., 2000, Further evidence is provided here to prove that PS1 is gamma-secretase. The next proof desired... 3 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Yasuda M. et al., 2000, The C-to-T transition mutation at position +12 of the intron following exon 10 of the tau gene... 3 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Fonseca MI. et al., 1999, The presence of racemized amino acid in amyloid may be important for plaque in a stable form but... 3 Jul 2002.
|
|
|
|
|
|
Mori H. on PAPER: Kinoshita A. et al., 2002, This nice paper evokes another question and mechanism on Abeta and APP-CT whether toxic Aβ... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Iwata N. et al., 2001, "It is highly likely that neprilysin is a key molecule to down-regulate of amyloid burden. It is... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Berezovska O. et al., 2001, "This may suggests an important clue to understand the physiological interaction, though... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Wittmann CW. et al., 2001, "The mechanism for tauopathy must be elucidated and accumulated from multiple attacks. This... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Sabo SL. et al., 2001, "This is an interesting paper to show the physiological function of FE65 in cell movement and... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Yan R. et al., 2001, "This presents a crucial result on the localization and function for BACE but the question... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Zhou B. et al., 2001, "This provides a great impact and concept to us. Ferrous accumulation diseases such as PKAN... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Rogaeva EA. et al., 2001, This is another peg to establish the role of presenilin molecules in AD, and tells us the... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Asthana S. et al., 2001, The high dose of estrogen replacement would be a potent therapeutic and its effect is expected... 29 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Ono K. et al., 2002, Nordihydroguaiaretic acid (NDGA) may be posotively considered as another therapeutic or... 28 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Wakabayashi K. et al., 1997, NACP is proposed to be the cause of familial PD and its occurrence in Lewy body enhances this... 3 Jun 2002.
|
|
|
|
|
|
Mori H. on PAPER: Chan SL. et al., 2000, It is curious how PS-1 dependent ER-stress is related with release of cellular Ca2+ in the... No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Morishima-Kawashima M. et al., 2000, ApoE4 is suggested to have a similar effect on Abeta42 as the early-onset genes like PS1, PS2 or... No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Kanai M. et al., 1998, The longitudinal study on amyloid and tau in CSF is important for AD diagnosis. The authors... No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Hanzel DK. et al., 1999, This is important for all morphologists to analyze quantitatively AD pathology. No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Guo Q. et al., 1998, It is very interesting how and when and where prostate apoptosis response-4 (Par-4) is altered... No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Yamazaki T. et al., 2001, It is not easy to understand the pathological function of Abeta42 in NPC. No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Leveugle B. et al., 1998, This study on heparin is expected to further our understanding of the interaction with amyloid... No date saved.
|
|
|
|
|
|
Mori H. on PAPER: Ivins KJ. et al., 1998, The practical evidence is provided by this article to show the local neurite degeneration... No date saved.
|
|
|
|
|
|
|
1 to 30 of 278 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
